On March 18, 2025 IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, reported that the Company will participate in multiple sessions at the Immuno-Oncology 360° (IO360°) Conference 2025, held March 24-26, 2025, in Boston, MA (Press release, In8bio, MAR 18, 2025, View Source [SID1234651219]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
William Ho, Chief Executive Officer and co-founder of IN8bio, will be Co-Chairing Day 2 of the conference starting at 8:15 AM EDT on March 25, 2025. He will deliver the welcoming remarks and discuss, "Tackling the Tough Questions in IO for Autoimmunity Disease." After, he will Chair the session, "State of the IO Market, Investments and Deals Plenary."
During the afternoon session, at 4:35 PM EDT, Mr. Ho will present on the topic of "Picking our Horse in the Race for Autoimmunity: The Gamma-Delta T cell Engager," and provide a corporate overview of IN8bio’s recently announced INB-619, T cell engager program for oncology and autoimmune diseases.
As co-chair and panelist, Mr. Ho expects to discuss the rationale and promise of a gamma-delta T cell engager in addressing autoimmunity, a rapidly emerging frontier for immunotherapies.
Presentation and Panel Details
Co-Chairs’ Welcome & Tackling the Tough Questions in IO for Autoimmunity Disease
Date/Time: March 25, 2025, at 8:15 AM EDT
Picking Our Horse in the Race for Autoimmunity: The Gamma-Delta T Cell Engager
Date/Time: March 25, 2025, at 4:35 PM EDT
For those interested in coordinating a time to meet with the IN8bio during IO360°, please email [email protected].
For more information about the event, visit https://io360summit.com.